R&D

PIPELINE

Sovargen will continue to expand competitive pipelines through our
proprietary science and technology.

Sovargen R&D Pipeline
Neurodevelopmental disorders Brain Tumor
Sovargen R&D Pipeline
Pipeline / Indication Target
identification		 Hit
Screening		 Lead
Optimization		 IND-
Enabling		 Phase 1 Phase 2
SVG103 FCD II1),TSC2), PROS3)
SVG105 Intractable focal epilepsy
including FCD II, TSC
SVG301 glioma
SVG303 GBM
SVG30X Brain Tumor

SVG103 FCD II1),TSC2), PROS3)

SVG105 Intractable focal epilepsy
including FCD II, TSC

SVG301 glioma

SVG303 GBM

SVG30X Brain Tumor

  • Focal Cortical Dysplasia
  • Tuberous Sclerosis Complex
  • PIK3CA-related overgrowth spectrum

Partnership

Sovargen will expedite and strengthen drug development with our unique
science and technology and also through open collaboration with global partners.

  • Bioinformatics & Artificial Intelligence

    Sovargen is awaiting its partners to collaborate on articulating root causes and mechanisms of CNS diseases and create a transformational long-term platform.
    Programs for Cooperation
    • Genomic data base target discovery
    • In vitro and in vivo Target validation
    • RNA drugs candidate screening & optimization

  • RNA
    Therapeutics

    Sovargen is awaiting its partners to design and materialize a new gene treatment technology
    Programs for Cooperation
    • ASO, siRNA therapy
    • mRNA therapy
    • chemical modification of ASO, siRNA, mRNA
    • Gene editing

  • Delivery System Development

    Sovargen is awaiting its partners to develop new drug delivery systems by which the in vivo stability and the permeability of the blood-brain barrier or BBB, will be further enhanced.
    Programs for Cooperation
    • Liposome
    • Exosome
    • Viral Vector

  • New Disease Models

    Sovargen is awaiting its partners to build disease-specific animal models with the new gene -editing technology to validate the stability and effectiveness of candidate substances.
    Programs for Cooperation
    • Human brain organoid, iPSC
    • Genetic engineered animal model